DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Thalomid (Thalidomide) - Myelodysplastic Syndrome - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Myelodysplastic Syndrome (12)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Thalomid (Thalidomide) where reactions include myelodysplastic syndrome. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Thalomid side effects in 73 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-10

Patient: 73 year old male, weighing 104.6 kg (230.1 pounds)

Reactions: Renal Failure, Sepsis, Myelodysplastic Syndrome

Adverse event resulted in: death

Drug(s) suspected as cause:
Thalomid
    Dosage: 100 milligram
    Administration route: Oral
    Start date: 2008-09-04
    End date: 2009-12-14

Melphalan Hydrochloride
    Dosage: 9 milligram/sq. meter
    Start date: 2008-09-04
    End date: 2009-12-14

Revlimid
    Dosage: 15 milligram
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2011-03-21

Prednisone TAB
    Dosage: 100 milligram
    Start date: 2008-09-04
    End date: 2009-12-14

Revlimid
    Dosage: 10 milligram
    Administration route: Oral
    Start date: 2011-04-19
    End date: 2011-07-26

Other drugs received by patient: Dexamethasone; Simvastatin; Garlic; Dilaudid; Pseudoephedrine HCL; Loperamide; Proair HFA; Talwin NX; Vitamin D; Ambien; Duragesic-100; Antacid Medicine (Homeopathic); MS Contin; Vitamin E; Magnesium Oxide; Aspirin; Neupogen; Miralax; Vitamin B-12



Possible Thalomid side effects in 73 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-10

Patient: 73 year old male, weighing 104.6 kg (230.1 pounds)

Reactions: Renal Failure, Sepsis, Myelodysplastic Syndrome

Adverse event resulted in: death

Drug(s) suspected as cause:
Melphalan Hydrochloride
    Dosage: 9 milligram/sq. meter
    Start date: 2008-09-04
    End date: 2009-12-14

Prednisone TAB
    Dosage: 100 milligram
    Start date: 2008-09-04
    End date: 2009-12-14

Thalomid
    Dosage: 100 milligram
    Administration route: Oral
    Start date: 2008-09-04
    End date: 2009-12-14

Revlimid
    Dosage: 15 milligram
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2011-03-21

Revlimid
    Dosage: 10 milligram
    Administration route: Oral
    Start date: 2011-04-19
    End date: 2011-07-26

Other drugs received by patient: Antacid Medicine (Homeopathic); Aspirin; Loperamide; Garlic; Miralax; Ambien; Dilaudid; Vitamin E; Simvastatin; Proair HFA; Duragesic-100; Dexamethasone; Neupogen; Vitamin B-12; Vitamin D; Talwin NX; MS Contin; Pseudoephedrine HCL; Magnesium Oxide



Possible Thalomid side effects in female

Reported by a physician from United States on 2012-07-06

Patient: female

Reactions: Neuropathy Peripheral, Myelodysplastic Syndrome, Breast Cancer in Situ, Deep Vein Thrombosis

Drug(s) suspected as cause:
Thalomid

Other drugs received by patient: Etoposide; Dexamethasone Sodium Phosphate; Cyclophosphamide; Velcade; Neupogen; Cisplatin



Possible Thalomid side effects in female

Reported by a physician from United States on 2012-07-02

Patient: female

Reactions: Neuropathy Peripheral, Myelodysplastic Syndrome, Breast Cancer in Situ, Deep Vein Thrombosis

Drug(s) suspected as cause:
Thalomid

Other drugs received by patient: Neupogen; Cisplatin; Cyclophosphamide; Velcade; Dexamethasone; Etoposide



Possible Thalomid side effects in 73 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-15

Patient: 73 year old male, weighing 104.6 kg (230.1 pounds)

Reactions: Renal Failure, Sepsis, Myelodysplastic Syndrome

Adverse event resulted in: death

Drug(s) suspected as cause:
Thalomid
    Dosage: 100 milligram
    Administration route: Oral
    Start date: 2008-09-04
    End date: 2009-12-14

Revlimid
    Dosage: 10 milligram
    Administration route: Oral
    Start date: 2011-04-19
    End date: 2011-07-26

Melphalan Hydrochloride
    Dosage: 9 milligram/sq. meter
    Start date: 2008-09-04
    End date: 2009-12-14

Revlimid
    Dosage: 15 milligram
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2011-03-21

Prednisone
    Dosage: 100 milligram
    Start date: 2008-09-04
    End date: 2009-12-14

Other drugs received by patient: Loperamide; Aspirin; Dexamethasone; Duragesic-100; Vitamin B-12; Proair HFA; Garlic; Miralax; Vitamin E; Pseudoephedrine HCL; Dilaudid; Neupogen; Talwin NX; Antacid Medicine (Homeopathic); Vitamin D; MS Contin; Simvastatin; Magnesium Oxide; Ambien



Possible Thalomid side effects in female

Reported by a physician from United States on 2012-06-12

Patient: female

Reactions: Neuropathy Peripheral, Myelodysplastic Syndrome, Breast Cancer in Situ, Deep Vein Thrombosis

Drug(s) suspected as cause:
Thalomid

Other drugs received by patient: Velcade; Cyclophosphamide; Dexamethasone; Cisplatin; Etoposide; Neupogen



Possible Thalomid side effects in female

Reported by a physician from United States on 2012-05-09

Patient: female

Reactions: Acute Myeloid Leukaemia, Myelodysplastic Syndrome

Adverse event resulted in: death

Drug(s) suspected as cause:
Thalomid
    Dosage: unknown
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2003-03-01

Thalomid
    Dosage: 100 milligram
    Administration route: Oral
    Indication: Myelodysplastic Syndrome
    Start date: 2012-01-01

Other drugs received by patient: Zometa; Dexamethasone; Decadron



Possible Thalomid side effects in 73 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-02

Patient: 73 year old male, weighing 104.6 kg (230.1 pounds)

Reactions: Myelodysplastic Syndrome

Drug(s) suspected as cause:
Melphalan Hydrochloride
    Dosage: 9 milligram/sq. meter
    Start date: 2008-09-04
    End date: 2009-12-14

Revlimid
    Dosage: 15 milligram
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2011-03-21

Revlimid
    Dosage: 10 milligram
    Administration route: Oral
    Start date: 2011-04-19
    End date: 2011-07-26

Thalomid
    Dosage: 100 milligram
    Administration route: Oral
    Start date: 2008-09-04
    End date: 2009-12-14

Prednisone
    Dosage: 100 milligram
    Start date: 2008-09-04
    End date: 2009-12-14

Other drugs received by patient: Duragesic-100; Antacid Medicine (Homeopathic); Vitamin D; Talwin NX; Dexamethasone; Proair HFA; Neupogen; Loperamide; Simvastatin; Garlic; Miralax; MS Contin; Ambien; Dilaudid; Vitamin B-12; Magnesium Oxide; Pseudoephedrine HCL; Vitamin E; Aspirin



Possible Thalomid side effects in female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-03-01

Patient: female

Reactions: Myelodysplastic Syndrome, Multiple Myeloma

Adverse event resulted in: death

Drug(s) suspected as cause:
Lenalidomide
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2007-04-09
    End date: 2008-01-29

Cyclophosphamide
    Indication: Multiple Myeloma

Etoposide
    Indication: Multiple Myeloma

Bortezomib
    Indication: Multiple Myeloma

Alkeran
    Indication: Multiple Myeloma

Doxorubicin HCL
    Indication: Multiple Myeloma

Vincristine
    Indication: Multiple Myeloma

Cisplatin
    Indication: Multiple Myeloma

Thalomid
    Administration route: Oral
    Indication: Multiple Myeloma

Dexamethasone
    Indication: Multiple Myeloma



Possible Thalomid side effects in male

Reported by a physician from United States on 2012-01-20

Patient: male, weighing 88.5 kg (194.8 pounds)

Reactions: Myelodysplastic Syndrome

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Thalomid



Possible Thalomid side effects in 52 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2011-10-18

Patient: 52 year old male, weighing 67.0 kg (147.4 pounds)

Reactions: Acute Myeloid Leukaemia, Myelodysplastic Syndrome

Drug(s) suspected as cause:
Cisplatin
    Indication: Multiple Myeloma
    Start date: 2005-06-29

Melphalan Hydrochloride
    Start date: 2009-10-15

Velcade
    Indication: Multiple Myeloma
    Start date: 2005-06-29

Thalomid
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2005-06-29
    End date: 2008-07-03

Melphalan Hydrochloride
    Indication: Multiple Myeloma

Etoposide
    Indication: Multiple Myeloma
    Start date: 2005-06-29

Dexamethasone
    Indication: Multiple Myeloma
    Start date: 2005-06-29
    End date: 2008-07-03

Doxorubicin HCL
    Indication: Multiple Myeloma
    Start date: 2005-06-29

Cyclophosphamide
    Indication: Multiple Myeloma
    Start date: 2005-06-29



Possible Thalomid side effects in 52 year old male

Reported by a health professional (non-physician/pharmacist) from United States on 2011-10-05

Patient: 52 year old male, weighing 67.0 kg (147.4 pounds)

Reactions: Acute Myeloid Leukaemia, Myelodysplastic Syndrome

Drug(s) suspected as cause:
Thalomid
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2005-06-29
    End date: 2008-07-03

Melphalan Hydrochloride
    Start date: 2009-10-15

Velcade
    Indication: Multiple Myeloma
    Start date: 2005-06-29

Melphalan Hydrochloride
    Indication: Multiple Myeloma

Cyclophosphamide
    Indication: Multiple Myeloma
    Start date: 2005-06-29

Dexamethasone
    Indication: Multiple Myeloma
    Start date: 2005-06-29
    End date: 2008-07-03

Doxorubicin HCL
    Indication: Multiple Myeloma
    Start date: 2005-06-29

Etoposide
    Indication: Multiple Myeloma
    Start date: 2005-06-29

Cisplatin
    Indication: Multiple Myeloma
    Start date: 2005-06-29

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017